• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgA肾病患者补体调节蛋白的肾小球沉积及血清水平

Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.

作者信息

Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R

出版信息

Clin Nephrol. 1984 Jun;21(6):335-40.

PMID:6205804
Abstract

We examined complement control proteins focusing on the role of modulating the complement activation in IgA nephropathy. Glomerular C4-binding protein (C4-bp) deposits were found in 60% of patients with IgA nephropathy, while C4 deposits were found in 30%. Glomerular deposits of beta 1H globulin (beta 1H) were found in 85% of patients with IgA nephropathy. The frequency of glomerular deposits of C4-bp tended to be higher in the group with deposits of various immunoglobulin types than in the group with deposits of IgA alone, and it increased parallel with the progression of glomerular histologic changes. The serum C4-bp level was higher in IgA nephropathy patients. No significant correlation was found between the serum level of C4-bp or beta 1H and the extent or distribution of tissue deposits of these complement control proteins. These results suggest that glomerular immune deposits in IgA nephropathy may be attributable to the activation not only of the alternative pathway but also of the classical pathway, the latter of which may take place locally in glomeruli with advanced histologic change or various immunoglobulin deposits in IgA nephropathy.

摘要

我们研究了补体调节蛋白,重点关注其在IgA肾病中调节补体激活的作用。在60%的IgA肾病患者中发现了肾小球C4结合蛋白(C4-bp)沉积,而C4沉积见于30%的患者。在85%的IgA肾病患者中发现了β1H球蛋白(β1H)的肾小球沉积。C4-bp肾小球沉积的频率在各种免疫球蛋白类型沉积的组中往往高于仅IgA沉积的组,并且它随着肾小球组织学变化的进展而增加。IgA肾病患者的血清C4-bp水平较高。未发现血清C4-bp或β1H水平与这些补体调节蛋白的组织沉积范围或分布之间存在显著相关性。这些结果表明,IgA肾病中的肾小球免疫沉积可能不仅归因于替代途径的激活,还归因于经典途径的激活,后者可能在IgA肾病中具有晚期组织学变化或各种免疫球蛋白沉积的肾小球局部发生。

相似文献

1
Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.IgA肾病患者补体调节蛋白的肾小球沉积及血清水平
Clin Nephrol. 1984 Jun;21(6):335-40.
2
Deposition of C4-binding protein and beta 1H globulin in kidneys of patients with IgA nephropathy.
Tokai J Exp Clin Med. 1981 Apr;6(2):217-22.
3
Double immunofluorescence studies of immunoglobulins, complement components and their control proteins in patients with IgA nephropathy.
Acta Pathol Jpn. 1982 Mar;32(2):251-6. doi: 10.1111/j.1440-1827.1982.tb02046.x.
4
Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.IgA 肾小球肾炎中的系膜 IgA2 沉积及凝集素途径介导的补体激活
Am J Kidney Dis. 2001 Nov;38(5):1082-8. doi: 10.1053/ajkd.2001.28611.
5
Correlation of paramesangial deposits and glomerular sclerosis and/or hyalinosis in patients with IgA nephropathy.IgA肾病患者系膜旁沉积物与肾小球硬化和/或玻璃样变的相关性
Tokai J Exp Clin Med. 1986 Oct;11(4):235-9.
6
Immunoglobulin A nephropathy.免疫球蛋白A肾病
Arch Intern Med. 1975 Sep;135(9):1217-23.
7
Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy.IgA肾病患者中通过凝集素途径对原位补体激活的调节。
Clin Nephrol. 2001 Mar;55(3):185-91.
8
Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy.特定补体表型和缺陷在IgA肾病临床表型中的作用。
Am J Med Sci. 1991 Feb;301(2):115-23. doi: 10.1097/00000441-199102000-00006.
9
Mesangial glomerulonephropathy with decreased circulating C4 and predominant mesangial C4 deposition in association with one null gene at the C4B locus.
Nephron. 1986;43(2):128-32. doi: 10.1159/000183811.
10
IgA nephropathy and significance of immunostaining data.IgA肾病及免疫染色数据的意义
Iran J Immunol. 2013 Dec;10(4):267-9.

引用本文的文献

1
Heterozygous mutations in factor H aggravate pathological damage in a stable IgA deposition model induced by cell wall extract.杂合性因子 H 突变加重了细胞壁提取物诱导的稳定 IgA 沉积模型中的病理性损伤。
Front Immunol. 2024 Mar 15;15:1368322. doi: 10.3389/fimmu.2024.1368322. eCollection 2024.
2
Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.斯巴森坦可改善 IgA 肾病小鼠模型中由 IgA1-IgG 免疫复合物引起的肾小球细胞过度增生和炎症基因网络。
Am J Physiol Renal Physiol. 2024 May 1;326(5):F862-F875. doi: 10.1152/ajprenal.00253.2023. Epub 2024 Mar 21.
3
IgA nephropathy.
IgA 肾病。
Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9.
4
Challenges in IgA Nephropathy Management: An Era of Complement Inhibition.IgA肾病管理中的挑战:补体抑制时代
Kidney Int Rep. 2023 Jun 21;8(9):1730-1740. doi: 10.1016/j.ekir.2023.06.010. eCollection 2023 Sep.
5
Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.IgA 肾病进展过程中尿补体蛋白的相对定量蛋白质组学分析。
PeerJ. 2023 Apr 11;11:e15125. doi: 10.7717/peerj.15125. eCollection 2023.
6
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.肾脏疾病与补体的作用:将补体与免疫效应途径和治疗联系起来。
Adv Immunol. 2021;152:1-81. doi: 10.1016/bs.ai.2021.09.001. Epub 2021 Nov 19.
7
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?补体在IgA肾病发病机制中的作用:补体靶向治疗是否正从罕见疾病转向更常见疾病?
J Clin Med. 2021 Oct 14;10(20):4715. doi: 10.3390/jcm10204715.
8
Complement Activation Is Associated With Crescents in IgA Nephropathy.补体激活与 IgA 肾病中的新月体相关。
Front Immunol. 2021 Sep 14;12:676919. doi: 10.3389/fimmu.2021.676919. eCollection 2021.
9
An Update on the Current State of Management and Clinical Trials for IgA Nephropathy.IgA肾病管理现状及临床试验的最新进展
J Clin Med. 2021 Jun 4;10(11):2493. doi: 10.3390/jcm10112493.
10
Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival.移植后 IgA 肾病的肾小球 C4d 与移植物存活率降低有关。
J Nephrol. 2021 Jun;34(3):839-849. doi: 10.1007/s40620-020-00914-x. Epub 2020 Dec 11.